ALNY vs J · P/E 76, rev $1.29B vs P/E 36, rev $4.08B
Alnylam Pharmaceuticals Inc (ALNY) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported J revenue for 2026-06-26 was $4.08B. Net income was $136.6M. Revenue was down 41.7% from 2026-03-27 to 2026-06-26. J currently screens at market cap $14.40B and trailing P/E 36.0.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the ALNY and J stock pages for the full models.
Not investment advice.